Enrolling 3,349 patients, the IVUS sub-study is part of the Cardiovascular Research Foundation's (CRF) ADAPT-DES study (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents), a prospective ...
Photo Credit: Prati F. When IVUS-OCT Guidance is a Need: Highly Calcified Lesions and ACS. Presented at TCT 2019. September 26, 2019. A three-way comparison of PCI guidance confirms that, when sizing ...
SAN DIEGO, CA—IVUS-guided implantation of drug-eluting stents results in lower rates of target vessel failure (TVF) by 1 year compared to angiography-guided procedures, according to results from a new ...
This approach significantly reduces the risk of future re-narrowing of the artery and improves long-term outcomes for ...
SAN DIEGO -- Implanting drug-eluting stents under intravascular ultrasound-guided (IVUS) guidance improves outcomes compared with angiography guidance, a randomized trial from China found. The primary ...
Please provide your email address to receive an email when new articles are posted on . Patients who underwent IVUS-guided PCI had more comorbidities but experienced less mortality, MI and repeat ...
LAS VEGAS — Among patients with chronic kidney disease from the ULTIMATE cohort, assignment to IVUS-guided drug-eluting stent implantation was linked to lower rates of target vessel failure compared ...
Amsterdam, Netherlands – 27 Aug 2023: Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding percutaneous coronary intervention (PCI), according to late ...
Intravascular ultrasound (IVUS)-guided stent implantation yielded significantly lower rates of major adverse cardiac events up to 5 years, compared with angiographic guidance, research suggests. The ...
Randomized to optical coherence tomography (OCT) or intravascular ultrasound (IVUS) guidance, patients who underwent percutaneous coronary intervention (PCI) with contemporary stents showed a decrease ...
Boston, MA - The New England Journal of Medicine (NEJM) has issued a Notice of Duplicate Publication for the ASPECT paclitaxel-eluting stent trial, published in the April 16, 2003 issue of the NEJM.
In the current issue of Cardiovascular Innovations and Applications (Volume3, Number 2, 2018, pp. 127-136(10); DOI https:/ / doi. org/ 10. 15212/ CVIA. 2017. 0029, Dhruv Mahtta, Ahmed N. Mahmoud, ...